Literature DB >> 30173594

Screening for gestational diabetes mellitus: one step versus two step approach. A meta-analysis of randomized trials.

Gabriele Saccone1, Adeeb Khalifeh2, Huda B Al-Kouatly3, Kerri Sendek3, Vincenzo Berghella3.   

Abstract

Objective: Worldwide controversy exists regarding the best approach and criteria for gestational diabetes mellitus (GDM) screening and diagnosis. The aim of this systematic review and meta-analysis of randomized trials was to assess the incidence of maternal and neonatal outcomes comparing the one step with the two step approach for the diagnosis of GDM.
Methods: Electronic databases were searched from their inception until June 2018. We included all the randomized trials comparing the one step versus the two step method for screening and diagnosis of GDM. The primary outcome was the incidence of large for gestational age (LGA), defined as birth weight >90th percentile. Meta-analysis was performed using the random effects model of DerSimonian and Laird, to produce summary treatment effects in terms of relative risk (RR) with 95% confidence interval (CI).
Results: Four randomized clinical trials (RCTs) (n = 2582 participants) were identified as relevant and included in the meta-analysis. Women screened with the one step approach had a significantly lower risk of adverse perinatal outcomes, including LGA (RR 0.46, 95% CI 0.25-0.83), admission to neonatal intensive care unit (NICU) (RR 0.49, 95% CI 0.29-0.84) and neonatal hypoglycemia (RR 0.52, 95% CI 0.28-0.95), compared to those randomized to the screening with the two step approach. The one step approach was also associated with lower mean birth weight (mean difference -112.91 grams, 95% CI -190.48 to -35.33). No significant difference in the incidence of GDM was found comparing the one step versus the two step approach (8.3 versus 4.4%; RR 1.60, 95% CI 0.93-2.75).Conclusions: This study provides high quality evidence that the diagnosis of GDM by the one step approach is associated with better perinatal outcomes, including lower incidences of LGA, NICU admission and neonatal hypoglycemia, compared to the two step approach. Based on these findings, we recommend screening of GDM using the one-step approach.

Entities:  

Keywords:  Diabetes; gestational diabetes mellitus; insulin; macrosomia; obesity

Mesh:

Year:  2018        PMID: 30173594     DOI: 10.1080/14767058.2018.1519543

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  6 in total

1.  Bridging Gaps and Understanding Disparities in Gestational Diabetes Mellitus to Improve Perinatal Outcomes.

Authors:  Sean S Daneshmand; Sharon Stortz; Robin Morrisey; Arij Faksh
Journal:  Diabetes Spectr       Date:  2019-11

Review 2.  Screening for Gestational Diabetes during the COVID-19 Pandemic-Current Recommendations and Their Consequences.

Authors:  Anca Maria Panaitescu; Anca Marina Ciobanu; Maria Popa; Irina Duta; Nicolae Gica; Gheorghe Peltecu; Alina Veduta
Journal:  Medicina (Kaunas)       Date:  2021-04-15       Impact factor: 2.430

Review 3.  Iranian Endocrine Society Guidelines for Screening, Diagnosis, and Management of Gestational Diabetes Mellitus.

Authors:  Majid Valizadeh; Farhad Hosseinpanah; Fahimeh Ramezani Tehrani; Hengameh Abdi; Ladan Mehran; Farzad Hadaegh; Atieh Amouzegar; Farzaneh Sarvghadi; Fereidoun Azizi
Journal:  Int J Endocrinol Metab       Date:  2020-12-23

4.  Metabolic associated fatty liver disease and adverse maternal and fetal outcomes: a systematic review and meta-analysis.

Authors:  Adinda Ayu Dyah; Rahadina Rahadina
Journal:  Clin Exp Hepatol       Date:  2021-09-20

Review 5.  The incidence of gestational diabetes mellitus among women with polycystic ovary syndrome: a meta-analysis of longitudinal studies.

Authors:  Qingzi Yan; Dan Qiu; Xiang Liu; Qichang Xing; Renzhu Liu; Yixiang Hu
Journal:  BMC Pregnancy Childbirth       Date:  2022-04-29       Impact factor: 3.105

Review 6.  A global view of hypertensive disorders and diabetes mellitus during pregnancy.

Authors:  Li Jiang; Kun Tang; Laura A Magee; Peter von Dadelszen; Alec Ekeroma; Xuan Li; Enyao Zhang; Zulfiqar A Bhutta
Journal:  Nat Rev Endocrinol       Date:  2022-09-15       Impact factor: 47.564

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.